Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Enamelast is a flavored, xylitol-sweetened dental varnish containing 5% sodium fluoride in a resin carrier. It is designed for professional topical application to teeth, primarily to prevent dental caries and treat tooth hypersensitivity. The product features a patented adhesion-promoting agent that enhances its retention on the tooth surface, allowing for superior and sustained fluoride release and uptake compared to other varnishes. This results in more effective remineralization of enamel and occlusion of dentinal tubules, reducing sensitivity. Enamelast is available in multiple flavors (including flavor-free) and delivery forms (unit-dose blister packs or syringes). Its smooth texture and nearly invisible appearance encourage patients to leave it on longer for maximum benefit[1][2][3][7][9]. The primary mechanism of action is the mechanical/chemical occlusion of dentinal tubules by sodium fluoride, which strengthens enamel through remineralization.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Enamelast.